Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults
Managing extracranial arteriovenous malformations is challenging. Sirolimus (rapamycin) is increasingly being used when surgery and embolization are not advised. Because of its anti-angiogenic properties here we report all extracranial arteriovenous malformation cases treated with sirolimus in 2 Fre...
Saved in:
Main Authors: | Romain Gabeff (Author), Olivia Boccara (Author), Véronique Soupre (Author), Gérard Lorette (Author), Christine Bodemer (Author), Denis Herbreteau (Author), Elsa Tavernier (Author), Annabel Maruani (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Beta-blockers on Extracranial Arteriovenous Malformations
by: Sarah Chastanet, et al.
Published: (2022) -
Anaesthetic management of a child with massive extracranial arteriovenous malformation
by: Faisal Shamim, et al.
Published: (2012) -
Topical rapamycin (sirolimus) for facial angiofibromas
by: Bhushan Madke
Published: (2013) -
Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
by: Shixiao Dong, et al.
Published: (2023) -
Characteristics, Natural Course and Treatment of Intramuscular Capillary-type Haemangioma: A Systematic Literature Review
by: Jordan Orly, et al.
Published: (2023)